Genome-wide association studies in type 2 diabetes
- Mark I. McCarthyAffiliated withOxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital Email author
- , Eleftheria Zeggini
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Despite numerous candidate gene and linkage studies, the field of type 2 diabetes (T2D) genetics had until recently succeeded in identifying few genuine disease-susceptibility loci. The advent of genomewide association (GWA) scans has transformed the situation, leading to an expansion in the number of established, robustly replicating T2D loci to almost 20. These novel findings offer unique insights into the pathogenesis of T2D and in the main point toward the etiologic importance of disorders of β-cell development and function. All associated variants have common allele frequencies in the discovery populations, and exert modest to small effects on the risk of disease, characteristics that limit their prognostic and diagnostic potential. However, ongoing studies focusing on the role of copy number variation and targeting low-frequency polymorphisms should identify additional T2D susceptibility loci, some of which may have larger effect sizes and offer better individual prediction of disease risk.
- Genome-wide association studies in type 2 diabetes
Current Diabetes Reports
Volume 9, Issue 2 , pp 164-171
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links